Saliva-based Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Saliva-based Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global saliva based screening market achieved a revenue of approximately US$ 360 million in 2024, and it is projected to reach a valuation of US$ 670 million by the end of 2031. Saliva-based testing has gained popularity due to its non-invasive nature and simplicity in sample collection, making it an attractive alternative to serum-based testing.

Key Market Insights

Saliva-based screening is becoming increasingly important in the detection of a wide range of diseases, including oral and systemic illnesses. The non-invasive nature of saliva collection, coupled with the presence of numerous disease indicators and biomarkers, has driven the adoption of this technology in diagnostics.

Market Growth Drivers

1. Innovation in Saliva Based Screening: The demand for rapid diagnosis of various diseases is fueling innovation in the field. Manufacturers are developing and introducing innovative solutions to meet the growing demand for quick disease detection, leading to increased competition in the market.

2. Prevalence of Infectious Diseases: The ongoing prevalence of infectious diseases, such as COVID-19, has led to increased approvals of practical and easy-to-use saliva-based test kits. These kits have further driven the demand for saliva-based screening.

3. Availability of Saliva Collection Devices: The increasing availability of saliva collection devices and the preference for non-invasive saliva tests over blood tests for disease diagnosis are contributing to market growth. Technological advancements are also driving product adoption.

Factors Impacting Market Growth

The emergence of new companies introducing testing kits that use nasal swabs and other specimens is limiting the growth of saliva-based screening, despite the advantages of saliva in terms of ease of collection and self-testing.

Booming U.S. Market

The United States is witnessing significant growth in saliva-based screening, driven by the popularity of self-testing and home-based kits. The user-friendliness of self-testing kits and their availability through various distribution channels, including online pharmacies and medicine stores, are contributing to this growth.

Prominent German Market

Germany offers substantial opportunities for manufacturers due to the importance of early disease diagnosis, particularly in managing infections with high mortality rates caused by mutant variations. Rapid test kits have become crucial in early diagnosis, further driving market growth.

Development in India

Initiatives by the Indian government and non-profit organizations are increasing public awareness about the importance of early disease diagnosis. Growing awareness, along with the popularity of self-detection kits for obtaining test results with lower cross-infection risks, is driving market development in India.

Competitive Landscape

Mergers and acquisitions have emerged as a key growth strategy for market participants, with many international corporations investing in research and development to create comprehensive solutions in saliva-based screening kits.

Key Companies Profiled:
• Thermo Fisher Scientific
• Hologic
• Qiagen
• Zymo Research Corporation
• DNA Genotek Inc.
• Invitek Molecular GmbH
• Salimetrics, LLC.
• BioChain Institute Inc.
• Mawi DNA Technologies LLC
• Cell Projects Ltd.
• Kyodo International, Inc.
• Spectrum Solutions
• NEOGEN Corporation
• Xiamen Zeesan Biotech Co., Ltd.
• Sedia Biosciences Corporation
• Biosynex SA
• Chembio Diagnostics, Inc.
• Creative Diagnostics
• OraSure Technologies

The global saliva-based screening market is poised for substantial growth due to its non-invasive nature and increasing demand for rapid and practical disease diagnosis.

Market Segmentation

Product:
• Saliva collection kits/devices
• Saliva nucleic acid purification kits
• Saliva base detection kits
PCR based
Rapid kits

Purpose:
• Research use only
• Diagnostics

Application:
• Infection analysis/detection
• Genomic analysis
• Proteomics
• Pharmacogenomics
• Liquid biopsy

End User:
• Hospitals & Clinics
• Diagnostic laboratories
• Academic & research institutes
• Biopharmaceuticals & CRO’s

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.